Telomir Pharmaceuticals, Inc. Other Liabilities
Telomir Pharmaceuticals, Inc. (TELO) had Other Liabilities of $93.43 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OtherLiabilities · last filed 2024-11-12
- 2024-09-30: Other Liabilities $93.43K.
- 2024-06-30: Other Liabilities $140.34K.
- 2024-03-31: Other Liabilities $7.90K.
- 2023-12-31: Other Liabilities $527.38K.
| Period end | Other Liabilities |
|---|---|
| 2024-09-30 | $93.43K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $140.34K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $7.90K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $527.38K 10-Q · filed 2024-11-12 |
| 2022-12-31 | $581.79K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |